Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ESAB Corporation filings document the regulatory record for an industrial manufacturer of welding, cutting and joining equipment and consumables. Its Form 8-K disclosures cover operating and financial results, material-event reporting, dividend and capital-structure matters, senior unsecured notes and related subsidiary guarantees.
Proxy and governance filings describe shareholder voting matters, director and officer changes, board committee assignments, executive compensation, director independence and related governance practices. The filing record also reflects public-company reporting following ESAB's 2022 registration as a standalone issuer.
RALES MITCHELL P reported acquisition or exercise transactions in this Form 4 filing.
ESAB Corp Executive Chair Mitchell P. Rales received a grant of 596 deferred stock units (DSUs) on June 30, 2026. These DSUs are payable solely in common stock and will be settled in shares at the earlier of his death or January 31 of the second calendar year after he retires from the Board. Following this grant, he directly holds 16,432 shares of ESAB common stock, with additional indirect holdings reported through a family trust, custodial accounts for his daughters, and a family partnership, some of which he disclaims beneficial ownership except for his pecuniary interest.
LUTZ ROBERT S reported acquisition or exercise transactions in this Form 4 filing.
ESAB Corp director Robert S. Lutz received a grant of 330 deferred stock units as compensation for Board service. Each unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of his cash retainer, vest immediately, and will be settled in ESAB common stock after he separates from the company.
Teirlinck Didier P reported acquisition or exercise transactions in this Form 4 filing.
ESAB Corp director Didier P. Teirlinck received a grant of 134 deferred stock units for Board service. These units were issued in lieu of his cash retainer, with each unit representing a contingent right to one share of ESAB common stock.
The deferred stock units vest immediately, meaning the director’s right to them is fully earned on the grant date. They will be settled in ESAB common stock after his separation from the company. Following this grant, Teirlinck holds 134 deferred stock units directly.
ESAB Corporation is registering 1,254,255 shares of common stock for resale by selling stockholders under a prospectus supplement dated June 26, 2026. The company states it is not selling any shares and will receive no proceeds from these resales.
The shares were acquired in a private placement pursuant to a Purchase Agreement dated February 2, 2026 and are held in funds or accounts advised or subadvised by T. Rowe Price. Percentage ownership calculations are based on 60,881,712 shares outstanding as of April 28, 2026. The prospectus supplement cites a closing NYSE price of $96.62 per share on June 23, 2026.
ESAB Corp reported that Executive Chair of the Board Mitchell P. Rales received a grant of 1,200,000 stock options on June 10, 2026. These performance stock options have an exercise price of $82.92 per share and expire on June 9, 2033.
The options become exercisable, if at all, in three tranches. Vesting depends on ESAB’s simple average closing share price on the NYSE exceeding specified stock price hurdles over any 30-day trailing period during a four-year window starting on the second anniversary of the grant, plus his continued employment through the fourth, fifth and sixth anniversaries and the company’s certification of the price hurdles.
ESAB Corp President and CEO Shyam Kambeyanda received a performance stock option grant covering 580,552 shares of ESAB common stock. The option has an exercise price of $82.92 per share and expires on June 9, 2033.
The award vests in three tranches based on ESAB’s achievement of specified performance criteria during a four-year period that starts on the second anniversary of the grant and ends on the sixth anniversary. Vesting also requires Kambeyanda’s continued service through the later of the fourth, fifth and sixth anniversaries of the grant date and the date when performance achievement is certified.
ESAB Corp granted Chief Human Resources Officer Michele Campion a performance stock option covering 52,250 shares of common stock at an exercise price of $82.92 per share. The option expires on June 9, 2033 and vests in three tranches tied to multi‑year performance goals and continued service.
ESAB Corp granted SVP and General Counsel Curtis E. Jewell a performance stock option covering 58,056 shares of common stock. The option has an exercise price of $82.92 per share and expires on June 9, 2033.
The award vests in three tranches based on ESAB meeting specified performance criteria during a four-year period starting on the second anniversary of the grant date and ending on the sixth anniversary. Vesting also requires Jewell’s continued service through the later of the fourth, fifth and sixth anniversaries and the date when ESAB certifies achievement of the applicable performance goals.
ESAB Corp reported that EVP and Chief Financial Officer R. Brent Jones received a grant of performance stock options covering 145,138 shares of common stock at an exercise price of $82.92 per share. These options vest in three tranches based on performance over a four-year period, starting on the second anniversary of the grant date. Vesting also requires his continued service through specified anniversaries and certification that ESAB met the related performance goals.